—
00:00
Growing Money
Growing Money
USD/RUB—
EUR/RUB—
Releases

GMP Labeling Marks Four Decades of Domestic Compliance Manufacturing

As global supply chain volatility persists, Granite Bay-based GMP Labeling is using Manufacturing Day 2026 to underscore its 40-year tenure as a domestic supplier of critical identification components, providing pharmaceutical and biotechnology firms with a stable alternative to international logistics for their essential regulatory compliance needs.

GMP Labeling Marks Four Decades of Domestic Compliance Manufacturing

Often dismissed as simple office supplies, labels for quality control and equipment status are vital links in the production chain. Material inconsistencies or shipping delays can trigger significant disruptions, complicating federal audits and risking the integrity of essential quality records. For medical device and pharmaceutical manufacturers, these small components are foundational to maintaining traceability in highly regulated environments.

General Manager Robin Kalsbeek emphasizes that these products serve as critical elements of compliance rather than mere consumables. By maintaining production within the United States since 1987, the company offers a buffer against the logistical risks that often plague overseas sourcing. Their ISO 9001-certified management system provides the documentation necessary for rigorous supplier evaluations, while specialized engineering ensures that labels remain legible under harsh conditions, including autoclave cycles, cryogenic storage, and chemical exposure. This focus on domestic reliability allows biotech firms to secure their supply chains through dedicated technical support and consistent, revision-controlled material availability.

Share

Comments (0)

Leave a comment

No comments yet. Be the first!